Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zain Shahid

Vascular Surgery Gainesville, FL Medical Doctor

NPI 1194167296 CMS profile 5700524

1600 Sw Archer Rd # Ng-45, Gainesville, FL 32610

Open in the dashboard

General payments

$21,100

113 records reported · program years 2019–2025

Research payments

$11,343

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zain Shahid of Gainesville, FL is reported in the CMS Open Payments database as having received $21,100 across 113 general payments and $11,343 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,193 30
2025 Research $11,343 6
2024 General $2,193 19
2023 General $8,949 44
2022 General $1,498 18
2019 General $268 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zain Shahid
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Zain Shahid were reported at $8,193. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Zain Shahid Vascular Surgery median Middle half National median
2019 $268 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $0 $471 $158–$1,421 $132
2022 $1,498 $725 $222–$2,183 $149
2023 $8,949 $836 $257–$2,440 $160
2024 $2,193 $909 $252–$2,619 $164
2025 $8,193 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $5,318 22 payments
  2. Cook Medical LLC $4,847 53 payments
  3. Cook Incorporated $3,844 12 payments
  4. Medtronic, Inc. $2,575 13 payments
  5. Wilson Cook Medical Incorporated $2,550 1 payment
  6. Cook Research Incorporated $772 1 payment
  7. Bolton Medical Inc $764 7 payments
  8. Medtronic Vascular, Inc. $268 2 payments
  9. CryoLife, Inc. $114 1 payment
  10. Terumo Medical Corporation $48 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $10,788 31 payments
  2. Food and Beverage $6,296 79 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,825 2 payments
  4. Education $191 1 payment
Products named General payments · program years 2019–2025
  1. Zenith Alpha Aortic Intervention $4,920 22 payments
  2. Product in Development $4,388 14 payments
  3. Zenith Spiral-Z $1,450 20 payments
  4. Heli-FX EndoAnchor System $1,400 5 payments
  5. ENDURANT IIS $935 6 payments
  6. TREO ABDOMINAL STENT-GRAFT SYSTEM $626 6 payments
  7. ZENITH ALPHA Non SBU - Cook Management $493 2 payments
  8. GORE TAG Thoracic Endoprosthesis $469 2 payments
  9. Zenith $422 6 payments
  10. GORE TAG Conformable Thoracic Endoprosthesis $296 2 payments
  11. Other $2,043 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Research Incorporated $11,343 6 payments

Billing to Medicare

Part B · data year 2024 · 118 billing codes

Paid by Medicare

$203,938

Medicare's payments for the services billed

Medicare patients

473

Average age 74

Services billed

1,123

198 women, 275 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 61%
Arthritis 56%
Chronic kidney disease 53%
Diabetes 43%
Heart failure 41%
COPD 39%
Atrial fibrillation 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record